MUN receives funding to accelerate cancer-related precision medicine

August 16, 2021
Memorial University will be receiving $3.6M from the Government of Canada and the Government of Newfoundland and Labrador to pursue a pilot project that will accelerate precision medicine in Atlantic Canada. MUN’s Atlantic Cancer Consortium (ACC) will use the funding for five projects. Projects will focus on the creation of provincial tumour biobanks, the development of a bioinformatics core, enrichment and expansion Beatrice Hunter Cancer Research Institute’s trainee program, and two projects on lung cancer and colorectal cancer. “This exciting initiative further enhances Memorial’s global reputation for leading-edge precision medicine and health-related studies,” said Dr Neil Bose, VP (research) at MUN. MUN (NL)